Professor Derek Blake

2019

• Chapman, R. M.et al. 2019. Convergent evidence that ZNF804A is a regulator of pre-messenger RNA processing and gene expression. Schizophrenia Bulletin 45(6), pp. 1267-1278. (10.1093/schbul/sby183)
• Cameron, D.et al. 2019. Transcriptional changes following cellular knockdown of the schizophrenia risk gene SETD1A are enriched for common variant association with the disorder. Molecular Neuropsychiatry 5(2), pp. 109-114. (10.1159/000497181)
• Lamb, R.et al. 2019. A novel TBK1 mutation in a family with diverse frontotemporal dementia spectrum disorders. Molecular Case Studies 5(3), article number: a003913. (10.1101/mcs.a003913)
• Okumura, N.et al. 2019. Effect of trinucleotide repeat expansion on the expression of TCF4 mRNA in Fuchs' endothelial corneal dystrophy. Investigative Ophthalmology & Visual Science 60(2), pp. 779. (10.1167/iovs.18-25760)

2018

• Forrest, M. P.et al. 2018. The psychiatric risk gene transcription factor 4 (TCF4) regulates neurodevelopmental pathways associated with schizophrenia, autism, and intellectual disability. Schizophrenia Bulletin 44(5), pp. 1100-1110. (10.1093/schbul/sbx164)
• Gyöngyösi, M.et al. 2018. Meta-analysis of cell therapy studies in heart failure and acute myocardial infarction. Circulation Research 123(2), pp. 301-308. (10.1161/CIRCRESAHA.117.311302)

2017

• Benson, M. A.et al. 2017. Ryanodine receptors are part of the myospryn complex in cardiac muscle. Scientific Reports 7(1), article number: 6312. (10.1038/s41598-017-06395-6)
• Petit, E. I.et al. 2017. Dysregulation of specialized delay/interference-dependent working memory following loss of Dysbindin-1A in schizophrenia-related phenotypes. Neuropsychopharmacology 42(6), pp. 1349-1360. (10.1038/npp.2016.282)
• Harvey, E.et al. 2017. Potency of human cardiosphere-derived cells from patients with ischemic heart disease is associated with robust vascular supportive ability. Stem Cells Translational Medicine 6(5), pp. 1399-1411. (10.1002/sctm.16-0229)
• Xiao, J.et al. 2017. Role of major and brain-specific Sgce isoforms in the pathogenesis of myoclonus-dystonia syndrome. Neurobiology of Disease 98, pp. 52-65. (10.1016/j.nbd.2016.11.003)
• Grütz, K.et al. 2017. Faithful SGCE imprinting in iPSC-derived cortical neurons: an endogenous cellular model of myoclonus-dystonia. Scientific Reports 7, article number: 41156. (10.1038/srep41156)

2016

• Waite, A. J.et al. 2016. Myoclonus dystonia and muscular dystrophy: ɛ-sarcoglycan is part of the dystrophin-associated protein complex in brain. Movement Disorders 31(11), pp. 1694-1703. (10.1002/mds.26738)

2015

• Koppers, M.et al. 2015. C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Annals of Neurology 78(3), pp. 426-438. (10.1002/ana.24453)

2014

• Peall, K. J.et al. 2014. SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype. Journal of Neurology 261(12), pp. 2296-2304. (10.1007/s00415-014-7488-3)
• Hill, M.et al. 2014. Association of Transcription Factor 4 (TCF4) variants with schizophrenia and intellectual disability. Current Behavioral Neuroscience Reports 1(4), pp. 206-214. (10.1007/s40473-014-0027-9)
• Peall, K. J.et al. 2014. SGCZ mutations are unlikely to be associated with myoclonus dystonia. Neuroscience 272, pp. 88-91. (10.1016/j.neuroscience.2014.04.034)
• Waite, A.et al. 2014. Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiology of Aging 35(7), pp. 1779.e5-1779.e13. (10.1016/j.neurobiolaging.2014.01.016)
• Forrest, M.et al. 2014. The emerging roles of TCF4 in disease and development. Trends in Molecular Medicine 20(6), pp. 322-331. (10.1016/j.molmed.2014.01.010)

2013

• Xu, L.et al. 2013. Adeno-associated virus 9 mediated FKRP gene therapy restores functional glycosylation of α-dystroglycan and improves muscle functions. Molecular Therapy 21(10), pp. 1832-40. (10.1038/mt.2013.156)
• Forrest, M.et al. 2013. Knockdown of human TCF4 affects multiple signaling pathways involved in cell survival, epithelial to mesenchymal transition and neuronal differentiation. PLoS ONE 8(8), pp. e73169. (10.1371/journal.pone.0073169)
• Peall, K. J.et al. 2013. SGCE mutations cause psychiatric disorders: clinical and genetic characterization. Brain 136(1), pp. 294-303. (10.1093/brain/aws308)

2012

• Forrest, M.et al. 2012. Functional analysis of TCF4 missense mutations that cause Pitt-Hopkins syndrome. Human Mutation 33(12), pp. 1676-1686. (10.1002/humu.22160)
• Waite, A. J., Brown, S. C. and Blake, D. J. 2012. The dystrophin-glycoprotein complex in brain development and disease [Review]. Trends in Neurosciences 35(8), pp. 487-496. (10.1016/j.tins.2012.04.004)
• Peall, K. J.et al. 2012. Myoclonus dystonia syndrome: SGCE mutations and psychiatric disease [Abstract]. Journal of Neurology 259, pp. S30-S30.
• Chapman, R. M.et al. 2012. Inducible over-expression and siRNA mediated knock-down of the schizophrenia susceptibility gene ZNF804A: Detection of altered gene expression and splicing using whole genome exon arrays. International Journal of Developmental Neuroscience 30(8), pp. 673-673. (10.1016/j.ijdevneu.2012.10.011)
• Morris, H. R.et al. 2012. Recent advances in the genetics of the ALS-FTLD complex. Current Neurology and Neuroscience Reports 12(3), pp. 243-250. (10.1007/s11910-012-0268-5)

2011

• Waite, A. J.et al. 2011. A gain-of-glycosylation mutation associated with myoclonus-dystonia syndrome affects trafficking and processing of mouse ε-sarcoglycan in the late secretory pathway. Human Mutation 32(11), pp. 1246-1258. (10.1002/humu.21561)
• Renton, A.et al. 2011. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72(2), pp. 257-268. (10.1016/j.neuron.2011.09.010)
• Talbot, K.et al. 2011. Synaptic dysbindin-1 reductions in schizophrenia occur in an isoform-specific manner indicating their subsynaptic location. PLoS ONE 6(3), article number: e16886. (10.1371/journal.pone.0016886)
• Peall, K. J.et al. 2011. Psychiatric disorders, myoclonus dystonia, and the epsilon-sarcoglycan gene: a systematic review. Movement Disorders 26(10), pp. 1939-1942. (10.1002/mds.23791)

2010

• Lu, P. J.et al. 2010. Mutations alter secretion of fukutin-related protein. Biochimica et Biophysica Acta - Molecular Basis of Disease 1802(2), pp. 253-258. (10.1016/j.bbadis.2009.10.016)
• Chan, Y. M.et al. 2010. Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies. Human Molecular Genetics 19(20), pp. 3995-4006. (10.1093/hmg/ddq314)

2009

• Borg, K.et al. 2009. Intragenic deletion of TRIM32 in compound heterozygotes with sarcotubular myopathy/LGMD2H. Human Mutation 30(10), pp. E831-E844. (10.1002/humu.21063)
• Locke, M.et al. 2009. TRIM32 is an E3 ubiquitin ligase for dysbindin. Human Molecular Genetics 18(13), pp. 2344-2358. (10.1093/hmg/ddp167)
• Waite, A. J.et al. 2009. The neurobiology of the dystrophin-associated glycoprotein complex. Annals of Medicine 41(5), pp. 344-359. (10.1080/07853890802668522)
• Tang, J.et al. 2009. Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression. Human Molecular Genetics 18(20), pp. 3851-3863. (10.1093/hmg/ddp329)

2008

• Hjermind, L. E.et al. 2008. No muscle involvement in myoclonus-dystonia caused by ɛ-sarcoglycan gene mutations. European Journal of Neurology 15(5), pp. 525-529. (10.1111/j.1468-1331.2008.02116.x)

2007

• Keramaris-Vrantsis, E.et al. 2007. Fukutin-related protein localizes to the Golgi apparatus and mutations lead to mislocalization in muscle in vivo. Muscle & Nerve 36(4), pp. 455-465. (10.1002/mus.20833)
• Schröder, J. E.et al. 2007. Dystroglycan regulates structure, proliferation and differentiation of neuroepithelial cells in the developing vertebrate CNS. Developmental Biology 307(1), pp. 62-78. (10.1016/j.ydbio.2007.04.020)
• Blake, D. J. 2007. Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin.. Schizophrenia bulletin 33(2), pp. 255-255.
• Esapa, C. T.et al. 2007. SGCE missense mutations that cause myoclonus-dystonia syndrome impair epsilon-sarcoglycan trafficking to the plasma membrane: modulation by ubiquitination and torsinA. Human Molecular Genetics 16(3), pp. 327-342. (10.1093/hmg/ddl472)
• Martin-Rendon, E. and Blake, D. J. 2007. Patenting human genes and stem cells. Recent Patents on DNA and Gene Sequences 1(1), pp. 25-34.

2006

• Talbot, K.et al. 2006. Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin. Human Molecular Genetics 15(20), pp. 3041-3054. (10.1093/hmg/ddl246)

2005

• Blake, D. J., Esapa, C. T. and McIlhinney, R. A. 2005. Fukutin-related protein mutations that cause congenital muscular dystrophy result in ER-retention of the mutant protein in cultured cells. Human Molecular Genetics 14(2), pp. 295-305. (10.1093/hmg/ddi026)
• Blake, D. J.et al. 2005. Glycosylation defects and muscular dystrophy. Advances in Experimental Medicine and Biology 564, pp. 97-98. (10.1007/0-387-25515-X_15)

2004

• Lien, C. F.et al. 2004. Differential spatio-temporal expression of alpha-dystrobrevin-1 during mouse development. Gene Expression Patterns 4(5), pp. 583-593. (10.1016/j.modgep.2004.01.015)
• Benson, M. A., Sillitoe, R. V. and Blake, D. J. 2004. Schizophrenia genetics: dysbindin under the microscope. Trends in Neurosciences 27(9), pp. 516-519. (10.1016/j.tins.2004.06.004)
• Talbot, K.et al. 2004. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. The Journal of Clinical Investigation 113(9), pp. 1353-1363. (10.1172/JCI200420425)
• Talbot, K.et al. 2004. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. The Journal of Clinical Investigation 113(9), pp. 1353-1363. (10.1172/JCI200420425)
• Benson, M. A., Tinsley, C. L. and Blake, D. J. 2004. Myospryn is a novel binding partner for dysbindin in muscle. Journal of Biological Chemistry 279(11), pp. 10450-10458. (10.1074/jbc.M312664200)

2003

• Esapa, C. T.et al. 2003. The effects of post-translational processing on dystroglycan synthesis and trafficking. FEBS Letters 555(2), pp. 209-216. (10.1016/S0014-5793(03)01230-4)
• Burgueno, J.et al. 2003. The adenosine A2A receptor interacts with the actin-binding protein  α-actinin. Journal of Biological Chemistry 278(39), pp. 37545-37552. (10.1074/jbc.M302809200)
• Muntoni, F.et al. 2003. 114th ENMC International Workshop on Congenital Muscular Dystrophy (CMD) 17?19 January 2003, Naarden, The Netherlands: (8th Workshop of the International Consortium on CMD; 3rd Workshop of the MYO-CLUSTER project GENRE). Neuromuscular Disorders 13(7-8), pp. 579-588. (10.1016/S0960-8966(03)00072-5)
• Li, W.et al. 2003. Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1) [Letter]. Nature Genetics 35(1), pp. 84-89. (10.1038/ng1229)
• Sillitoe, R. V.et al. 2003. Abnormal dysbindin expression in cerebellar mossy fiber synapses in the mdx mouse model of Duchenne muscular dystrophy. Journal of Neuroscience 23(16), pp. 6576-6585.
• Sillitoe, R.et al. 2003. Abnormal dysbindin expression in cerebellar mossy fiber synapses in the mdx mouse model of Duchenne muscular dystrophy.. Journal of Neuroscience 23(16), pp. 6576-6585.
• Mercuri, E.et al. 2003. Phenotypic spectrum associated with mutations in the fukutin-related protein gene. Annals of Neurology 53(4), pp. 537-542. (10.1002/ana.10559)
• Martin-Rendon, E. and Blake, D. J. 2003. Protein glycosylation in disease: new insights into the congenital muscular dystrophies. Trends in Pharmacological Sciences 24(4), pp. 178-183. (10.1016/S0165-6147(03)00050-6)
• Topaloglu, H.et al. 2003. FKRP gene mutations cause congenital muscular dystrophy, mental retardation, and cerebellar cysts. Neurology 60(6), pp. 988-992. (10.1212/01.WNL.0000052996.14099.DC)

2002

• Blake, D. J.et al. 2002. Functional requirements for fukutin-related protein in the Golgi apparatus. Human Molecular Genetics 11(26), pp. 3319-3331. (10.1093/hmg/11.26.3319)
• Muntoni, F.et al. 2002. Defective glycosylation in muscular dystrophy. The Lancet 360(9343), pp. 1419-1421. (10.1016/S0140-6736(02)11397-3)
• Blake, D. J. 2002. Dystrobrevin dynamics in muscle-cell signalling: a possible target for therapeutic intervention in Duchenne muscular dystrophy?. Neuromuscular Disorders 12, pp. S110. (10.1016/S0960-8966(02)00091-3)
• Blake, D. J. and Martin-Rendon, E. 2002. Intermediate filaments and the function of the dystrophin-protein complex. Trends in Cardiovascular Medicine 12(5), pp. 224-228. (10.1016/S1050-1738(02)00166-4)
• Blank, M., Blake, D. J. and Kröger, S. 2002. Molecular diversity of the dystrophin-like protein complex in the developing and adult avian retina. Neuroscience 111(2), pp. 259-273. (10.1016/S0306-4522(02)00032-5)
• Blake, D. J.et al. 2002. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiological Reviews 82(2), pp. 291-329. (10.1152/physrev.00028.2001)
• Brockington, M.et al. 2002. The gene for a novel glycosyltransferase is mutated in congenital muscular dystrophy MDC1C and limb girdle muscular dystrophy 2I [Editorial]. Neuromuscular Disorders 12(3), pp. 233-234. (10.1016/S0960-8966(01)00325-X)

2001

• Marangi, P. A.et al. 2001. Acetylcholine receptors are required for agrin-induced clustering of postsynaptic proteins. The EMBO Journal 20(24), pp. 7060-7073. (10.1093/emboj/20.24.7060)
• Brockington, M.et al. 2001. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin 2 deficiency and abnormal glycosylation of -dystroglycan. American Journal of Human Genetics 69(6), pp. 1198-1209. (10.1086/324412)
• , . 2001. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Human Molecular Genetics 10(25), pp. 2851-2859. (10.1093/hmg/10.25.2851)
• Blake, D. J.et al. 2001. Golgi-localisation of fukutin and fukutin-related protein: implications for muscular dystrophy. Molecular Biology of the Cell 12, pp. 85A-85A.
• Loh, N. Y.et al. 2001. Role of β-dystrobrevin in nonmuscle dystrophin-associated protein complex-like complexes in kidney and liver. Molecular and Cellular Biology 21(21), pp. 7442-7448. (10.1128/MCB.21.21.7442-7448.2001)
• Brickington, M.et al. 2001. A novel glycosyltransferase is mutated in a form of congenital muscular dystrophy with secondary laminin alpha 2 deficiency and abnormal glycosylation of alpha-dystroglycan. American Journal of Human Genetics 69(4), pp. 229-229.
• Brockington, M.et al. 2001. A new gene encoding a fukutin-like protein and its analysis in patients with congenital muscular dystrophy [Abstract]. Neuromuscular Disorders 11(6-7), pp. 635-635.
• Benson, M. A.et al. 2001. Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. Journal of Biological Chemistry 276(26), pp. 24232-24241. (10.1074/jbc.M010418200)
• Newey, S. E.et al. 2001. Syncoilin, a novel member of the intermediate filament superfamily that interacts with alpha-dystrobrevin in skeletal muscle. Journal of Biological Chemistry 276(9), pp. 6645-6655. (10.1074/jbc.M008305200)
• Newey, S. E.et al. 2001. Syncoilin, a novel member of the intermediate filament superfamily that interacts with α-dystrobrevin in skeletal muscle. Journal of Biological Chemistry 276(9), pp. 6645-6655. (10.1074/jbc.M008305200)
• Newey, S. E.et al. 2001. A novel mechanism for modulating synaptic gene expression: differential localization of alpha-dystrobrevin transcripts in skeletal muscle. Molecular and Cellular Neuroscience 17(1), pp. 127-140. (10.1212/01.wnl.0000302174.08951.cf.)
• Newey, S. E.et al. 2001. A novel mechanism for modulating synaptic gene expression: differential localization of α-dystrobrevin transcripts in skeletal muscle. Molecular and Cellular Neuroscience 17(1), pp. 127-140. (10.1006/mcne.2000.0918)

2000

• Newey, S. E.et al. 2000. Alternative splicing of dystrobrevin regulates the stoichiometry of syntrophin binding to the dystrophin protein complex. Current Biology 10(20), pp. 1295-1298. (10.1016/S0960-9822(00)00760-0)
• Loh, N. Y.et al. 2000. Assembly of multiple dystrobrevin-containing complexes in the kidney. Journal of Cell Science 113(15), pp. 2715-2724.
• Blake, D. J. and Kröger, S. 2000. The neurobiology of Duchenne muscular dystrophy: learning lessons from muscle?. Trends in Neurosciences 23(3), pp. 92-99. (10.1016/S0166-2236(99)01510-6)

1999

• Blake, D. J.et al. 1999. Different dystrophin-like complexes are expressed in neurons and glia. Journal of Cell Biology 147(3), pp. 645-658. (10.1083/jcb.147.3.645)
• Blank, M.et al. 1999. Dystrophin and beta-dystroglycan in photoreceptor terminals from normal and mdx3Cv mouse retinae. European Journal of Neuroscience 11(6), pp. 2121-2133. (10.1046/j.1460-9568.1999.00636.x)
• Holzfeind, P. J.et al. 1999. Tissue-selective Expression of alpha-Dystrobrevin is Determined by Multiple Promoters. Journal of Biological Chemistry 274(10), pp. 6250-6258. (10.1074/jbc.274.10.6250)
• Blake, D. J.et al. 1999. Dystrophin-binding proteins in the brain. Journal of Neurochemistry 73, pp. S93-S93.

1998

• Loh, N. Y.et al. 1998. Genomic organization and refined mapping of the mouse beta-dystrobrevin gene. Mammalian Genome 9(11), pp. 857-862.
• Loh, N. Y.et al. 1998. Genomic organization and refined mapping of the mouse β-dystrobrevin gene. Mammalian Genome 9(11), pp. 857-862. (10.1007/s003359900883)
• Nawrotzki, R.et al. 1998. Characterisation of alpha-dystrobrevin in muscle. Journal of Cell Science 111(17), pp. 2595-2605.
• Vater, R.et al. 1998. Utrophin mRNA expression in muscle is not restricted to the neuromuscular junction. Molecular and Cellular Neuroscience 10(5-6), pp. 229-242. (10.1006/mcne.1998.0661)
• Blake, D. J.et al. 1998. beta-dystrobrevin, a member of the dystrophin-related protein family. Proceedings of the National Academy of Sciences of the United States of America 95(1), pp. 241-246. (10.1073/pnas.95.1.241)
• Blake, D. J.et al. 1998. β-dystrobrevin, a member of the dystrophin-related protein family. Proceedings of the National Academy of Sciences of the United States of America 95(1), pp. 241-246.

1997

• Blake, D. J.et al. 1997. The function dystrophin-related and -associated proteins in the brain. Journal of Neurochemistry 69(S), pp. S123-S123.
• Blake, D. J.et al. 1997. A novel dystrophin-associated protein in brain. American Journal of Human Genetics 61(4), pp. A8-A8.
• Loh, N. Y.et al. 1997. Beta-dystrobrevin; a new member of the dystrophin-related protein family. American Journal of Human Genetics 61(4), pp. A177-A177.
• Metzinger, L.et al. 1997. Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy. Human Molecular Genetics 6(7), pp. 1185-1191. (10.1093/hmg/6.7.1185)
• Ponting, C. P.et al. 1997. PDZ domains: targeting signalling molecules to sub-membranous sites. Bioessays 19(6), pp. 469-479. (10.1002/bies.950190606)
• Ambrose, H. J.et al. 1997. Genomic organization of the mouse dystrobrevin gene: comparative analysis with the dystrophin gene. Genomics 39(3), pp. 359-369. (10.1006/geno.1996.4515)

1996

• Picketts, D. J.et al. 1996. ATRX encodes a novel member of the SNF2 family of proteins: mutations point to a common mechanism underlying the ATR-X syndrome. Human Molecular Genetics 5(12), pp. 1899-1907. (10.1093/hmg/5.12.1899)
• Morrison, K. E.et al. 1996. Novel transcribed sequences represented in the complex genomic region 5q13. Acta Biochimica et Biophysica 1308(2), pp. 97-102. (10.1016/0167-4781(96)00097-8)
• Nawrotzki, R., Blake, D. J. and Davies, K. E. 1996. The genetic basis of neuromuscular disorders. Trends in Genetics 12(8), pp. 294-298. (10.1016/0168-9525(96)10033-0)
• Theodosiou, A. M.et al. 1996. A member of the MAP kinase phosphatase gene family in mouse containing a complex trinucleotide repeat in the coding region. Human Molecular Genetics 5(5), pp. 675-684. (10.1093/hmg/5.5.675)
• Blake, D. J.et al. 1996. Isoform diversity of dystrobrevin, the murine 87-kDa postsynaptic protein. Journal of Biological Chemistry 271(13), pp. 7802-7810. (10.1074/jbc.271.13.7802)
• Zuelling, R. A.et al. 1996. Cloning of the rat utrophin and characterization of an alternate transcript. Journal of Muscle Research and Cell Motility 17(1), pp. 110-110.
• Zuellig, R. A.et al. 1996. Cloning of the rat utrophin and characterization of an alternate transcript. Journal of Muscle Research and Cell Motility 17(1), pp. 110-110.
• Blake, D. J., Tinsley, J. M. and Davies, K. E. 1996. Utrophin: a structural and functional comparison to dystrophin. Brain Pathology 6(1), pp. 37-47. (10.1111/j.1750-3639.1996.tb00781.x)
• Ponting, C. P.et al. 1996. ZZ and TAZ: new putative zinc fingers in dystrophin and other proteins. Trends in Biochemical Sciences 21(1), pp. 11-13. (10.1016/S0968-0004(06)80020-4)

1995

• Millwood, I. Y.et al. 1995. Two polymorphic dinucleotide repeats in the rat dystrophin gene, including the conserved 3' UTR repeat. Mammalian Genome 6(9), pp. 668-669.
• Davies, K. E., Tinsley, J. M. and Blake, D. J. 1995. Molecular analysis of Duchenne muscular dystrophy: past, present, and future. Annals of the New York Academy of Sciences 758, pp. 287-296. (10.1111/j.1749-6632.1995.tb24834.x)
• Blake, D. J.et al. 1995. G-Utrophin, the autosomal homologue of dystrophin Dp116, is expressed in sensory ganglia and brain. Proceedings of the National Academy of Sciences of the United States of America 92(9), pp. 3697-3701. (10.1073/pnas.92.9.3697)
• Blake, D. J.et al. 1995. Coiled-coil regions in the carboxy-terminal domains of dystrophin and related proteins: potentials for protein-protein interactions. Trends in Biochemical Sciences 20(4), pp. 133-135. (10.1016/S0968-0004(00)88986-0)
• Pasquini, F.et al. 1995. The effect of glucocorticoids on the accumulation of utrophin by cultured normal and dystrophic human skeletal muscle satellite cells. Neuromuscular Disorders 5(2), pp. 105-114. (10.1016/0960-8966(94)00042-8)

1994

• Brookes, A. J.et al. 1994. Cloning the shared components of complex DNA resources. Human Molecular Genetics 3(11), pp. 2011-2017. (10.1093/hmg/3.11.2011)
• Tinsley, J. M.et al. 1994. Increasing complexity of the dystrophin-associated protein complex. Proceedings of the National Academy of Sciences of the United States of America 91(18), pp. 8307-8313.
• Schofield, J. N.et al. 1994. Apo-dystrophin-1 and apo-dystrophin-2, products of the Duchenne muscular dystrophy locus: expression during mouse embryogenesis and in cultured cell lines. Human Molecular Genetics 3(8), pp. 1309-1316. (10.1093/hmg/3.8.1309)
• Davies, K.et al. 1994. Possible roles for utrophin in gene-therapy of duchenne muscular-dystrophy. Journal of Cellular Biochemistry 1994(18A), pp. 188-188.
• Blake, D. J., Tinsley, J. M. and Davies, K. E. 1994. The emerging family of dystrophin-related proteins. Trends in Cell Biology 4(1), pp. 19-23. (10.1016/0962-8924(94)90034-5)

1993

• Pearce, M.et al. 1993. The utrophin and dystrophin genes share similarities in genomic structure. Human Molecular Genetics 2(11), pp. 1765-1772. (10.1093/hmg/2.11.1765)
• Tinsley, J. M.et al. 1993. Dystrophin and related proteins. Current Opinion in Genetics & Development 3(3), pp. 484-490. (10.1016/0959-437X(93)90124-8)
• Tinsley, J. M., Blake, D. J. and Davies, K. E. 1993. Apo-dystrophin-3: a 2.2kb transcript from the DMD locus encoding the dystrophin glycoprotein binding site. Human Molecular Genetics 2(5), pp. 521-524. (10.1093/hmg/2.5.521)
• Blake, D. 1993. Dystrophin and dystrophin-related proteins: a review of protein and RNA studies. Neuromuscular Disorders 3(1), pp. 5-21. (10.1016/0960-8966(93)90037-K)

1992

• Blake, D. J.et al. 1992. Characterization of a 4.8kb transcript from the Duchenne muscular dystrophy locus expressed in Schwannoma cells. Human Molecular Genetics 1(2), pp. 103-109. (10.1093/hmg/1.2.103)
• Tinsley, J. M.et al. 1992. Primary structure of dystrophin-related protein. Nature 360(6404), pp. 591-593. (10.1038/360591a0)
• thi Man, N.et al. 1992. Utrophin, the autosomal homologue of dystrophin, is widely-expressed and membrane-associated in cultured cell lines. FEBS Letters 313(1), pp. 19-22. (10.1016/0014-5793(92)81174-K)

1991

• Coleman, M. P.et al. 1991. Genetic and physical mapping around the properdin P gene. Genomics 11(4), pp. 991-996. (10.1016/0888-7543(91)90024-9)
• Sellar, G. C., Blake, D. J. and Reid, K. B. 1991. Characterization and organization of the genes encoding the A-, B- and C-chains of human complement subcomponent C1q. The complete derived amino acid sequence of human C1q. Biochemical Journal 274(2), pp. 481-490.
• Sellar, G. C., Blake, D. J. and Reid, K. B. 1991. Characterization and organization of the genes encoding the A-, B- and C-chains of human complement subcomponent C1q. The complete derived amino acid sequence of human C1q. Biochemical Journal 274(2), pp. 481-490. (10.1042/bj2740481)

1989

• Knott, V., Blake, D. J. and Brownlee, G. G. 1989. Completion of the detailed restriction map of the E.coli genome by the isolation of overlapping cosmid clones. Nucleic Acids Research 17(15), pp. 5901-5912. (10.1093/nar/17.15.5901)
• Blake, D. J. and Brownlee, G. 1989. Deletion of the mcf.2 transforming gene in 2 hemophilia-b inhibitor patients. Cytogenetics and Cell Genetics 51(1-4), pp. 963-963.
• Blake, D. J. and Brownlee, G. G. 1989. Deletion of the MCF.2 transforming gene in 2 Hemophilia-B inhibitor patients [Abstract]. Cytogenetics and Cell Genetics 51(1-4), pp. 963.

1988

• Anson, D.et al. 1988. Nullisomic deletion of the mcf.2 transforming gene in two haemophilia B patients.. EMBO Journal 7(9), pp. 2795-2799.
• Anson, D. S.et al. 1988. Nullisomic deletion of the mcf.2 transforming gene in two haemophilia B patients. EMBO Journal 7(9), pp. 2795-2799.

1987

• Blake, D. J., Knott, V. and Brownlee, G. 1987. A random cosmid contig approach to gene-mapping. Cytogenetics and Cell Genetics 46(1), pp. 581-581.
• Blake, D. J., Knott, V. and Brownlee, G. 1987. A random cosmid contig approach to gene-mapping [Abstract]. Cytogenetics and Cell Genetics 46(1-4), pp. 581. (10.1159/000316989)